Evolutionary Systems Therapy for Personality Pathology
Launched by TAGES ONLUS · May 14, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new type of therapy called Evolutionary Systems Therapy, aimed at helping people with personality disorders. This therapy has been tested before, but this trial will explore how well it works for different types of personality disorders in both adolescents and young adults. The goal is to see if this therapy can be a helpful option for people struggling with these conditions.
To participate in the trial, you need to be diagnosed with a personality disorder and be able to read and sign a consent form. However, individuals with certain conditions, like schizophrenia, bipolar disorder, or autism, won't be eligible. If you join the study, you can expect to engage in therapy sessions and provide feedback about your experiences. The trial is currently recruiting participants of all genders, between the ages of 18 and 65. This could be an opportunity to try a new treatment to help manage personality disorders.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being diagnosed with personality pathology in accordance with Structured Clinical Interview for DSM-5 - Alternative Model of Personality Disorders Module I
- • Being capable of read and sign the inform consent form
- Exclusion Criteria:
- • Being diagnosed with schizophrenia spectrum disorders and other psychosis
- • Being diagnosed with bipolar disorders
- • Being diagnosed with autism spectrum disorder
- • Being diagnosed with intellectual disability
- • Being under any psychopharmacological or psychosocial treatment
About Tages Onlus
Tages Onlus is a prominent non-profit organization dedicated to advancing research and clinical trials in the field of rare diseases, particularly those affecting pediatric populations. With a strong commitment to improving patient outcomes, Tages Onlus collaborates with healthcare professionals, academic institutions, and industry partners to foster innovative therapeutic solutions. By focusing on patient-centered approaches and leveraging cutting-edge methodologies, the organization aims to enhance the understanding and treatment of complex medical conditions, ultimately striving to ensure that every affected individual has access to the best possible care and support.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Firenze, Fi, Italy
Patients applied
Trial Officials
Simone Cheli, PhD
Principal Investigator
Tages Onlus
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported